Bills · S 3551
IN COMMITTEE· 119TH CONGRESS
Senate BillS 3551Health
PROTECT for Rare Act
INTRO DEC 17· LAST ACTION DEC 17
READING
8MIN
COSPONSORS
1
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill addresses a significant challenge for people with rare diseases: getting insurance coverage for their often expensive and specialized medications. Many drugs used for rare conditions might be effective but not have specific FDA approval or official listing for every single rare condition they treat, leading to coverage denials. This can leave patients without access to crucial treatments or facing immense financial burdens.
If this bill becomes law, it could mean more people with rare diseases can access life-changing or life-sustaining treatments without having to battle their insurance providers extensively or face crippling out-of-pocket costs. If it doesn't pass, these individuals will likely continue to encounter difficulties and denials when seeking coverage for treatments that are medically supported by scientific evidence but not officially listed for their specific rare condition, hindering their access to necessary care.
KEY PROVISIONS
3AI-extractedPROVISION 01
Amends Medicare Part B (medical insurance) and Part D (prescription drug coverage) definitions of "medically accepted indication" to specifically include drugs used for rare diseases (affecting 200,000 or fewer individuals). This is allowed when the drug's use is supported by peer-reviewed medical literature and not specifically contraindicated by the FDA or other official compendia.
This broadens what Medicare considers a legitimate reason for drug coverage, making it easier for beneficiaries with rare diseases to get their necessary medications covered.
PROVISION 02
Changes the definition of "medically accepted indication" for Medicaid covered outpatient drugs to include treatments for rare diseases if supported by peer-reviewed medical literature, clinical guidelines, or an expert in the condition, and not specifically contraindicated.
This ensures Medicaid recipients with rare diseases have similar expanded access to drug coverage as Medicare beneficiaries, addressing a critical gap for low-income individuals.
PROVISION 03
Requires private group health plans and health insurance issuers to establish an expedited (faster) appeal process for denials of coverage for drugs treating rare diseases. This process applies when the drug's use is supported by FDA labeling or peer-reviewed literature and not contraindicated.
This speeds up the review process for patients whose critical rare disease medications have been denied by private insurance, potentially reducing dangerous delays in treatment.
SPONSORSHIP
1 + 1
R· North Carolina
YRS IN OFFICE
11
BILLS LED
58
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 1 REP 0 IND 0
ACTION TIMELINE
2 EVENTSDEC 17
Introduced in Senate
DEC 17
Read twice and referred to the Committee on Finance.
BILL INFO
TypeSenate Bill
NumberS 3551
Congress119th
StatusIn Committee
IntroducedDec 17, 2025
Last actionDec 17, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · FINANCE COMMITTEE · INTRODUCED DEC 17, 2025
Senate BillS 3551Health
PROTECT for Rare Act
INTRODUCED DEC 17, 2025· LAST ACTION DEC 17, 2025
PASSAGE CHANCES
—%
READING
8 min
COSPONSORS
1
COMPLEXITY
Moderate
